The role of mediastinal and multi-organ CT scans in staging presumable surgical candidates with non-small-cell lung cancer
- PMID: 2828729
- DOI: 10.1007/BF02470635
The role of mediastinal and multi-organ CT scans in staging presumable surgical candidates with non-small-cell lung cancer
Abstract
In order to evaluate the role of CT scan and bone scan in staging patients with non-small-cell lung cancer presumably indicated for surgery, 70 consecutive patients who underwent thoracotomy were reviewed. Most of them received mediastinal and multi-organ (brain, liver and adrenal) CT scans and a bone scan. In the most recent 40 of the 70 patients, CT findings of the mediastinal lymph nodes were compared to the pathology following complete sampling. The overall accuracy of the mediastinal CT was 60.0 per cent (12 true positive and 12 true negative), but the negative predictable value was 12/(12 + 3) or 80.0 per cent, whereas 3 were false negatives though they showed an acceptable postoperative course. Sixteen out of 21 patients with one, or at the most, three enlarged nodes detected on CT also did well postoperatively and retrospectively, were considered not to have required mediastinoscopy. A group of patients showing no, or at the most, three enlarged mediastinal lymph nodes on CT may be considered as candidates for surgery even without mediastinoscopy. Multi-organ survey by means of CT was believed cost-ineffective and omittable. Bone scan however, retrospectively detected three true positives among 20 patients with a positive uptake, so that it cannot be omitted out of hand, though further examination of this point is required.
Similar articles
-
[Risk factor analysis of mediastinal lymph node metastasis in non-small cell lung cancer patients and the strategy of mediastinoscopy prior to surgery].Zhonghua Zhong Liu Za Zhi. 2009 Jun;31(6):456-9. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 19950559 Chinese.
-
Positron emission tomography-computed tomography compared with invasive mediastinal staging in non-small cell lung cancer: results of mediastinal staging in the early lung positron emission tomography trial.J Thorac Oncol. 2011 Aug;6(8):1367-72. doi: 10.1097/JTO.0b013e318220c912. J Thorac Oncol. 2011. PMID: 21587082 Clinical Trial.
-
Is mediastinoscopy still the gold standard to evaluate mediastinal lymph nodes in patients with non-small cell lung carcinoma?Thorac Cardiovasc Surg. 2012 Mar;60(2):116-21. doi: 10.1055/s-0030-1271148. Epub 2011 Jun 20. Thorac Cardiovasc Surg. 2012. PMID: 21692019
-
Pre- and intra-operative mediastinal staging in non-small-cell lung cancer.Swiss Med Wkly. 2011 Mar 8;141:w13168. doi: 10.4414/smw.2011.13168. eCollection 2011. Swiss Med Wkly. 2011. PMID: 21384283 Review.
-
Radiologic staging of lung cancer.J Thorac Imaging. 1999 Oct;14(4):235-46. doi: 10.1097/00005382-199910000-00003. J Thorac Imaging. 1999. PMID: 10524804 Review.
Cited by
-
Incidence and consequences of bone metastases in lung cancer patients.J Bone Oncol. 2013 Jan 17;2(1):22-9. doi: 10.1016/j.jbo.2012.12.004. eCollection 2013 Feb. J Bone Oncol. 2013. PMID: 26909268 Free PMC article.
-
Mortality following bone metastasis and skeletal-related events among patients 65 years and above with lung cancer: A population-based analysis of U.S. Medicare beneficiaries, 1999-2006.Lung India. 2013 Jan;30(1):20-6. doi: 10.4103/0970-2113.106127. Lung India. 2013. PMID: 23661912 Free PMC article.
-
Impact of neuroimaging in the pretreatment evaluation of early stage non-small cell lung cancer.Heliyon. 2020 Jun 29;6(6):e04319. doi: 10.1016/j.heliyon.2020.e04319. eCollection 2020 Jun. Heliyon. 2020. PMID: 32637704 Free PMC article.
-
Cost-effectiveness associated with the diagnosis and staging of non-small-cell lung cancer.Jpn J Thorac Cardiovasc Surg. 2001 Jan;49(1):1-10. doi: 10.1007/BF02913116. Jpn J Thorac Cardiovasc Surg. 2001. PMID: 11233235
-
Omission of bone scanning according to staging guidelines leads to futile therapy in non-small cell lung cancer.Eur J Nucl Med Mol Imaging. 2004 Jul;31(7):964-8. doi: 10.1007/s00259-004-1492-2. Epub 2004 Feb 28. Eur J Nucl Med Mol Imaging. 2004. PMID: 14991241 Clinical Trial.